Moreover, through the lentiviral transduction of two different shRNAs (shERα#1 and shERα#2) or the treatment with a selective ERα antagonist, we proved that the regulatory pathway is through the production of macrophage CXCL12 to activate its receptor, CXCR4, on lung cancer cells. Here, CXCL12 is linked to lung carcinoma.